Rocephin and Veramyst drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Rocephin (ceftriaxone sodium) and Veramyst (fluticasone furoate). Common drug interactions include cataract among females and dehydration among males.
The phase IV clinical study analyzes what interactions people have when they take Rocephin and Veramyst. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Rocephin?
Rocephin has active ingredients of ceftriaxone sodium. It is often used in infection. eHealthMe is studying from 15,665 Rocephin users. Check the latest studies of Rocephin.
What is Veramyst?
Veramyst has active ingredients of fluticasone furoate. It is often used in allergies. eHealthMe is studying from 3,444 Veramyst users. Check the latest studies of Veramyst.
13 people who take Rocephin and Veramyst together, and have interactions are studied.

What are the common drug interactions of Rocephin and Veramyst, by gender? *:
female:
- Cataract (clouding of the lens inside the eye)
- Dehydration (dryness resulting from the removal of water)
- Electrolyte imbalance
- Fear
- Gastroenteritis (inflammation of stomach and intestine)
- Heart rate decreased
- Hypokalaemia (low potassium)
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
- Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
- Surgery
male:
- Dehydration (dryness resulting from the removal of water)
- Dermatitis acneiform (dermatoses including acne vulgaris, rosacea, folliculitis, and perioral dermatitis)
- Fall
- Stomatitis (inflammation of mucous membrane of mouth)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus)
- Femoral hernia, obstructive (when a part of the intestine becomes intertwined with the hernia, causing an intestinal obstruction)
- Small intestinal obstruction (blockage in small intestine)
What are the common drug interactions of Rocephin and Veramyst, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Dehydration (dryness resulting from the removal of water)
- Anxiety
- Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
- Surgery
- Vitreous floaters (spots before the eyes)
- Hypoaesthesia (reduced sense of touch or sensation)
- International normalised ratio increased
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Photopsia (presence of perceived flashes of light)
- Haematuria (presence of blood in urine)
What are the existing conditions these people have? *
- Seasonal Allergy (allergic condition due to certain season): 3 people, 23.08%
- Pneumonia: 3 people, 23.08%
- Pain: 3 people, 23.08%
- Nausea (feeling of having an urge to vomit): 3 people, 23.08%
- High Blood Pressure: 3 people, 23.08%
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 3 people, 23.08%
- Dehydration (dryness resulting from the removal of water): 3 people, 23.08%
- Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 2 people, 15.38%
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 7.69%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Rocephin and Veramyst?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Rocephin and Veramyst:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rocephin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Veramyst:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Rocephin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Veramyst and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ceftriaxone sodium and fluticasone furoate (the active ingredients of Rocephin and Veramyst, respectively), and Rocephin and Veramyst (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Heparin Lock Flush cause Pancreatitis? - 3 seconds ago
- Could Methotrexate cause Human Herpes Virus 6 Serology Positive? - 11 seconds ago
- Drug interactions of Enulose and Lexapro - 14 seconds ago
- Drug interactions of Inderal and Albuterol - 20 seconds ago
- Drug interactions of Apidra and Embolex - 21 seconds ago
- Could Tetrabenazine cause Visual Acuity Reduced? - 25 seconds ago
- Could Rezulin cause Blood Bicarbonate Decreased? - 26 seconds ago
- Drug interactions of Eliquis and Epivir - 36 seconds ago
- Could Olmesartan Medoxomil cause Hyperglycemia? - 41 seconds ago
- Could Remicade cause Disease Recurrence? - 43 seconds ago